Research Analysts’ Weekly Ratings Updates for Trupanion (TRUP)

Several analysts have recently updated their ratings and price targets for Trupanion (NASDAQ: TRUP):

• 8/26/2026 – Trupanion was upgraded by Weiss Ratings from “hold (c-)” to “hold (c)”.
• 8/26/2026 – Trupanion was downgraded by Piper Sandler from “overweight” to “neutral”. They now have a $32.00 price target on the stock, down from $45.00.
• 8/24/2026 – Trupanion was downgraded by Zacks Research from “strong-buy” to “hold”.
• 8/20/2026 – Trupanion had its price target raised by Stifel Nicolaus from $28.00 to $29.00. They now have a “hold” rating on the stock.
• 8/12/2026 – Trupanion was upgraded by Weiss Ratings from “sell (d+)” to “hold (c-)”.
• 7/24/2026 – Trupanion was upgraded by Zacks Research from “hold” to “strong-buy”.
• 7/15/2026 – Trupanion was given a new $42.00 price target by Atlantic Securities.

Insiders Place Their Bets

In other Trupanion news, CEO Margaret Tooth sold 978 shares of Trupanion stock in a transaction that occurred on Tuesday, August 11th. The stock was sold at an average price of $29.05, for a total value of $28,410.90. Following the completion of the sale, the chief executive officer directly owned 175,401 shares in the company, valued at approximately $5,095,399.05. The trade was a 0.55% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Fawwad Qureshi sold 6,111 shares of the stock in a transaction that occurred on Wednesday, August 26th. The stock was sold at an average price of $30.01, for a total value of $183,391.11. Following the transaction, the chief financial officer owned 4,230 shares in the company, valued at $126,942.30. The trade was a 59.09% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders sold 12,046 shares of company stock worth $356,210. 5.58% of the stock is owned by corporate insiders.

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.